LinkSpine hires Tom McLeer as VP of sales and marketing: 5 notes

Rockaway, N.J.-based LinkSpine has named Tom McLeer its new vice president of sales and marketing.

Advertisement

Here are five things to know:

 

1. Mr. McLeer most recently served as Carlsbad, Calif.-based Alphatec Spine’s senior vice president of U.S. commercial operations.

 

2. LinkSpine president Dennis Farrell said, “Tom’s deep leadership experience in spine and familiarity with novel technologies will be invaluable to us as we continue to expand our less invasive Midline Choice product portfolio.”

 

3. LinkSpine strives to develop surgical morbidity-reducing solutions that can be placed with minimal fluoroscopy and shorter learning curves than tubular MIS techniques.

 

4. Midline Choice, the company’s midline fusion portfolio, includes CorticaLink and FacetLink. Each kit includes various screws and devices to allow the surgeon to intra-operatively create a less invasive fusion construct for each patient.

 

5. Mr. McLeer said, “I was drawn to LinkSpine’s dedicated focus on improving patient outcomes — and it’s innovative portfolio of powerful, yet simple solutions for less invasive surgery. The devices are novel, elegant and intuitive and fulfill a desire for a simple, less invasive approach to lumbar surgery.”

 

More device articles:
Vertebral Technologies goes global

How Supreme Court nominee Neil Gorsuch could help medical device companies — 5 notes

GOP healthcare plan to kill medical device tax — 5 observations

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new product launches and leadership appointments, here are seven key headlines from Stryker in the first quarter of 2026.…

  • Xtant Medical’s 2025 revenue reached $133.9 million, a 14% increase year over year, according to financial results posted March 31.…

Advertisement

Comments are closed.